Labcorp has completed its acquisition of Millennium Health, expanding its national toxicology testing network.

New England Biolabs will present new multiomic cell-free DNA and RNA workflows, enzymatic methylation profiling, and a PCR ...

FDA grants Breakthrough Device Designation to Primaa’s Cleo Skin AI pathology tool, which now has both CE-IVDR and FDA status ...

BIOTYPE and APIS Assay Technologies partner to commercialize ExaccType ESR1 and DPYD molecular testing kits for breast cancer mutation and chemotherapy toxicity detection.

Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.

Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...

Hepta reports its AI-based blood test matched MRE in identifying treatment-eligible MASH fibrosis in an independent Madrigal ...

Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...

A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.

Siemens Healthineers will separate its in vitro diagnostics business as Olyrian Diagnostics, aiming to complete the ...

A study in Gynecologic Oncology reports that a Mercy BioAnalytics blood test measuring cancer-linked proteins may detect ...

A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...